Company profile
Protekt Therapeutics company profile
ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Business identity
- Website
- https://www.protektx.com
- Contact email
- [email protected]
- Phone number
- +972-54-6491370
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2015-12-01, Month
Headquarters
- Headquarters
- Ness Ziona, Central District, Israel
- Postal code
- 7403635
- Country code
- IL
- Continent
- Asia